MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis

Erika Huijser; Corine Van Helden - Meeuwsen; NMS Groot; Iris Bodewes; MJ Wahadat; Marco Schreurs; Paul van Daele; V.A.S.H. Dalm; Jan van Laar; P.M. van Hagen; M Waris; Sylvia Kamphuis; Marjan Versnel

doi:10.1093/rheumatology/kez078

MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis

Erika Huijser, Corine Van Helden - Meeuwsen, NMS Groot, Iris Bodewes, MJ Wahadat, Marco Schreurs, Paul van Daele, V.A.S.H. Dalm, Jan van Laar, P.M. van Hagen, M Waris, Sylvia Kamphuis, Marjan Versnel

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1302-1303
Number of pages	2
Journal	Rheumatology
Volume	58
Issue number	7
DOIs	https://doi.org/10.1093/rheumatology/kez078
Publication status	Published - 2019

Access to Document

10.1093/rheumatology/kez078

http://hdl.handle.net/1765/117935

Cite this

Huijser, E., Van Helden - Meeuwsen, C., Groot, NMS., Bodewes, I., Wahadat, MJ., Schreurs, M., van Daele, P., Dalm, V. A. S. H., van Laar, J., van Hagen, P. M., Waris, M., Kamphuis, S., & Versnel, M. (2019). MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis. Rheumatology, 58(7), 1302-1303. https://doi.org/10.1093/rheumatology/kez078

@article{759442323555487b90f948aefdac9e24,

title = "MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis",

author = "Erika Huijser and {Van Helden - Meeuwsen}, Corine and NMS Groot and Iris Bodewes and MJ Wahadat and Marco Schreurs and {van Daele}, Paul and V.A.S.H. Dalm and {van Laar}, Jan and {van Hagen}, P.M. and M Waris and Sylvia Kamphuis and Marjan Versnel",

year = "2019",

doi = "10.1093/rheumatology/kez078",

language = "Undefined/Unknown",

volume = "58",

pages = "1302--1303",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "7",

}

Huijser, E, Van Helden - Meeuwsen, C, Groot, NMS, Bodewes, I, Wahadat, MJ, Schreurs, M , van Daele, P , Dalm, VASH , van Laar, J , van Hagen, PM, Waris, M, Kamphuis, S & Versnel, M 2019, 'MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis', Rheumatology, vol. 58, no. 7, pp. 1302-1303. https://doi.org/10.1093/rheumatology/kez078

TY - JOUR

T1 - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis

AU - Huijser, Erika

AU - Van Helden - Meeuwsen, Corine

AU - Groot, NMS

AU - Bodewes, Iris

AU - Wahadat, MJ

AU - Schreurs, Marco

AU - van Daele, Paul

AU - Dalm, V.A.S.H.

AU - van Laar, Jan

AU - van Hagen, P.M.

AU - Waris, M

AU - Kamphuis, Sylvia

AU - Versnel, Marjan

PY - 2019

Y1 - 2019

U2 - 10.1093/rheumatology/kez078

DO - 10.1093/rheumatology/kez078

M3 - Article

VL - 58

SP - 1302

EP - 1303

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 7

ER -